Adam Freund

Adam Freund is a life sciences entrepreneur and executive with a Ph.D. in molecular and cell biology. He has 16 years of experience in research and drug development, specializing in various therapeutic modalities including gene therapy, small molecule, large molecule, and cell therapy.

He is skilled in building and leading teams with complex scientific goals and excels at program strategy development, experiment prioritization, addressing critical steps, and meeting timelines. He has a track record of successfully leading cross-functional teams from target discovery to first-in-human study design.

Adam Freund has a strong educational background, having studied Ph.D. in Molecular and Cell Biology at the University of California, Berkeley, Biotech entrepreneurship at the University of California, San Francisco, and B.S. in Materials Science and Engineering at Stanford University.

His professional experience includes being the Founder and CEO at Arda Therapeutics, Scientific Advisor at Etalon Diagnostics, Principal Investigator at Calico Life Sciences, Postdoctoral Fellow at Stanford University School of Medicine, Postdoctoral Fellow at The Buck Institute for Research on Aging, and a Graduate Student at UC Berkeley.